FAKE DRUGS ALERT IN US
News | 20 June 2012
The US FDA is also planning to introduce a Generic Drug User Fee Act (GDUFA) to curb the import of generic drugs into that country. This Act will empower the ...
Click on the link to read the full article at pharmabiz.com
(This link will open in a new window)
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
